N-Acetylglucosaminyltransferase v regulates TGF-β response in hepatic stellate cells and the progression of steatohepatitis

Glycobiology

Volumn 22, Issue 6, 2012, Pages 778-787

  Kamada, Yoshihiro ^a   Mori, Kanako ^a   Matsumoto, Hitoshi ^a   Kiso, Shinichi ^a   Yoshida, Yuichi ^a   Shinzaki, Shinichiro ^a   Hiramatsu, Naoki ^a   Ishii, Mayuko ^a   Moriwaki, Kenta ^a   Kawada, Norifumi ^b   Takehara, Tetsuo ^a   Miyoshi, Eiji ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

GnT V; Liver fibrosis; Steatohepatitis; TGF 1; Th1 cytokine

Indexed keywords

COLLAGEN TYPE 1; CYCLOOXYGENASE 2; N ACETYLGLUCOSAMINYLTRANSFERASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL DIET; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE COURSE; DNA MICROARRAY; GENE EXPRESSION; LIPID DIET; LIVER FIBROSIS; LYMPHOCYTIC INFILTRATION; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STELLATE CELL; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; CYCLOOXYGENASE 2; FATTY LIVER; HEPATIC STELLATE CELLS; MALE; MICE; MICE, TRANSGENIC; N-ACETYLGALACTOSAMINYLTRANSFERASES; PYRAZOLES; SULFONAMIDES; TRANSFORMING GROWTH FACTOR BETA;

MURINAE; MUS; MUS MUSCULUS;

EID: 84860380612     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cws012     Document Type: Article

References (27)

1. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, et al. 2002. Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 123: 134-140.
2. Demetriou M, Granovsky M, Quaggin S, Dennis JW. 2001. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature. 409: 733-739.
3. Deushi M, Nomura M, Kawakami A, Haraguchi M, Ito M, Okazaki M, Ishii H, Yoshida M. 2007. Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome. FEBS Lett. 581: 5664-5670.
4. Ford ES, Giles WH, Dietz WH. 2002. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA. 287: 356-359.
5. Gao Y, Song LX, Jiang MN, Ge GY, Jia YJ. 2008. Effects of traditional Chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis. Inflammation. 31: 121-132.
6. Granovsky M, Fata J, Pawling J, Muller WJ, Khokha R, Dennis JW. 2000. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med. 6: 306-312.
7. Haukeland JW, Damas JK, Konopski Z, Loberg EM, Haaland T, Goverud I, Torjesen PA, Birkeland K, Bjoro K, Aukrust P. 2006. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol. 44: 1167-1174.
8. Hui AY, Dannenberg AJ, Sung JJ, Subbaramaiah K, Du B, Olinga P, Friedman SL. 2004. Prostaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells. J Hepatol. 41: 251-258.
9. Hyogo H, Tazuma S, Arihiro K, Iwamoto K, Nabeshima Y, Inoue M, Ishitobi T, Nonaka M, Chayama K. 2008. Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia. Metabolism. 57: 1711-1718.
10. Kristensen DB, Kawada N, Imamura K, Miyamoto Y, Tateno C, Seki S, Kuroki T, Yoshizato K. 2000. Proteome analysis of rat hepatic stellate cells. Hepatology. 32: 268-277.
11. Lau KS, Dennis JW. 2008. N-Glycans in cancer progression. Glycobiology. 18: 750-760.
12. Lee RT, Lee YC. 2000. Affinity enhancement by multivalent lectincarbohydrate interaction. Glycoconj J. 17: 543-551.
13. Li MO, Flavell RA. 2008. TGF-beta: A master of all T cell trades. Cell. 134: 392-404.
14. Massague J. 2000. How cells read TGF-beta signals. Nat Rev Mol Cell Biol. 1: 169-178.
15. Matsuzawa N, Takamura T, Kurita S, Misu H, Ota T, Ando H, Yokoyama M, Honda M, Zen Y, Nakanuma Y, et al. 2007. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology. 46: 1392-1403.
16. Miyoshi E, Ihara Y, Nishikawa A, Saito H, Uozumi N, Hayashi N, Fusamoto H, Kamada T, Taniguchi N. 1995. Gene expression of N- acetylglucosaminyltransferases III and V: A possible implication for liver regeneration. Hepatology. 22: 1847-1855.
17. Miyoshi E, Nishikawa A, Ihara Y, Gu J, Sugiyama T, Hayashi N, Fusamoto H, Kamada T, Taniguchi N. 1993. N-acetylglucosaminyltransferase III and V messenger RNA levels in LEC rats during hepatocarcinogenesis. Cancer Res. 53: 3899-3902.
18. Morgan R, Gao G, Pawling J, Dennis JW, Demetriou M, Li B. 2004. N-acetylglucosaminyltransferase V (Mgat5)-mediated N-glycosylation negatively regulates Th1 cytokine production by T cells. J Immunol. 173: 7200-7208.
19. Ohtsubo K, Marth JD. 2006. Glycosylation in cellular mechanisms of health and disease. Cell. 126: 855-867.
20. Park HJ, Partridge E, Cheung P, Pawling J, Donovan R, Wrana JL, Dennis JW. 2006. Chemical enhancers of cytokine signaling that suppress microfilament turnover and tumor cell growth. Cancer Res. 66: 3558-3566.
21. Partridge EA, Le Roy C, Di Guglielmo GM, Pawling J, Cheung P, Granovsky M, Nabi IR, Wrana JL, Dennis JW. 2004. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science. 306: 120-124.
22. Taniguchi N, Ihara S, Saito T, Miyoshi E, Ikeda Y, Honke K. 2001. Implication of GnT-V in cancer metastasis: A glycomic approach for identification of a target protein and its unique function as an angiogenic cofactor. Glycoconj J. 18: 859-865.
23. Taniguchi N, Miyoshi E, Ko JH, Ikeda Y, Ihara Y. 1999. Implication of N-acetylglucosaminyltransferases III and V in cancer: Gene regulation and signaling mechanism. Biochim Biophys Acta. 1455: 287-300.
24. Terao M, Ishikawa A, Nakahara S, Kimura A, Kato A, Moriwaki K, Kamada Y, Murota H, Taniguchi N, Katayama I, et al. 2011. Enhanced epithelialmesenchymal transition-like phenotype in N-acetylglucosaminyltransferase V transgenic mouse skin promotes wound healing. J Biol Cem. 286: 28303-28311.
25. Yasutake K, Nakamuta M, Shima Y, Ohyama A, Masuda K, Haruta N, Fujino T, Aoyagi Y, Fukuizumi K, Yoshimoto T, et al. 2009. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: The significance of dietary cholesterol. Scand J Gastroenterol. 44: 471-477.
26. Yoshimura A, Wakabayashi Y, Mori T. 2010. Cellular and molecular basis for the regulation of inflammation by TGF-beta. J Biochem. 147: 781-792.
27. Zhao Y, Sato Y, Isaji T, Fukuda T, Matsumoto A, Miyoshi E, Gu J, Taniguchi N. 2008. Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J. 275: 1939-1948.